Meng, R.D., C.C. Shelton, YM Li, LX Qin, Daniel Notterman, and Gary Schwartz. 2009. “Gamma-Secretase Inhibitors Abrogate Oxaliplatin-Induced Activation of the Notch-1 Signaling Pathway in Colon Cancer Cells Resulting in Enhanced Chemosensitivity.”. Cancer Research 69 (2): 573-82. Publisher’s Version: gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.